Premium Doctors’ Advances in Light-Based Aesthetic Technologies: Efficacy Across Skin Types

Background: Light-based aesthetic technologies, including lasers (picosecond, Nd:YAG, diode, alexandrite), Intense Pulsed Light (IPL), Photodynamic Therapy (PDT), and Light-Emitting Diodes (LED)/Photobiomodulation (PBM), are pivotal in addressing dermatological conditions such as hair reduction, pigmented and vascular lesions, acne, skin rejuvenation, and scar improvement. These modalities face challenges in darker Fitzpatrick Skin Types (FST IV–VI) due to melanin competition, increasing risks of post-inflammatory hyperpigmentation (PIH), burns, and scarring. Advances in device design, wavelength selection, pulse duration, and cooling systems, along with tools like the Excessive Setting Index of Clinical Fluence (EICF), have enhanced safety and efficacy across all skin types. This review synthesizes their mechanisms, applications, and challenges, emphasizing tailored protocols and practitioner expertise. Methods: A systematic search of PubMed, Scopus, Web of Science, and Google Scholar identified peer-reviewed articles (2014–2025) using terms like "light-based aesthetic technologies," "lasers," "IPL," "PDT," "LED," and "Fitzpatrick skin types." Inclusion criteria encompassed randomized controlled trials, systematic reviews, meta-analyses, and studies addressing efficacy and safety across FST I–VI. Non-peer-reviewed sources, non-English articles, and studies lacking methodological rigor were excluded. Data were extracted on mechanisms, applications, outcomes, and limitations, then synthesized thematically. Methodological quality was assessed using AMSTAR 2 guidelines. Results: Picosecond lasers excel in pigmentation and rejuvenation, with EICF optimizing safety in FST IV–VI. Nd:YAG (1064 nm) and diode lasers are effective for hair reduction in darker skin, requiring longer pulses (16–22 ms) and cooling. IPL treats multiple chromophores but risks PIH in FST IV–VI (up to 60% incidence). PDT reduces acne lesions (85.7% improvement in FST I–IV) and enhances rejuvenation, while LED/PBM safely improves acne and collagen production across all skin types. Combination therapies (e.g., IPL with topical agents) enhance outcomes. PIH remains a challenge in darker skin, necessitating careful parameter adjustments. Conclusions: Light-based technologies have advanced significantly, offering safe and effective treatments across FST I–VI. Tailored protocols, longer wavelengths, cooling systems, and combination therapies mitigate risks like PIH. Further research is needed for robust data on FST V–VI, novel photosensitizers, and adaptive devices to ensure equitable outcomes. Practitioner expertise and patient education are critical for optimizing results in aesthetic dermatology.